Hyloris Pharmaceuticals SA (EBR:HYL)
5.84
-0.14 (-2.34%)
Sep 26, 2025, 5:03 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €163.52 million as of September 26, 2025. Its market cap has decreased by -2.01% in one year.
Market Cap
163.52M
Enterprise Value
146.05M
Revenue
8.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.84
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 163.52M, a decrease of -33.18%. That is a compound annual growth rate of -7.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 163.52M | -10.70% |
Dec 31, 2024 | 183.12M | -48.71% |
Dec 29, 2023 | 357.00M | 14.84% |
Dec 30, 2022 | 310.88M | -30.44% |
Dec 31, 2021 | 446.90M | 82.11% |
Dec 31, 2020 | 245.41M | 0.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
argenx SE | 37.53B |
UCB SA | 37.41B |
Financière de Tubize | 7.08B |
Fagron NV | 1.44B |
Ion Beam Applications | 306.13M |
Onward Medical | 221.64M |
Nyxoah | 144.13M |
Sequana Medical NV | 49.95M |